GlassScriptPhysician profile
Joel Hansen
NPI 1598324154
$4,512.85
in general payments reported to CMS, 2019-2025
19 companies · $359 in 2025
The $359 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $237 · 2020: $243 · 2021: $1,014 · 2022: $868 · 2023: $1,154 · 2024: $637 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,150.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $1,164.16 | 2021-2025 | Acuvue |
| Bausch & Lomb Americas INC. | $762.23 | 2022-2025 | Infuse, Miebo, Btod |
| Alcon Vision LLC | $554.59 | 2019-2023 | Total30 |
| Allergan, INC. | $439.34 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $375.66 | 2020-2023 | |
| Tarsus Pharmaceuticals, INC. | $167.51 | 2024-2025 | Xdemvy |
| Regeneron Healthcare Solutions, INC. | $132.63 | 2022 | |
| Horizon Therapeutics Plc | $121.83 | 2022 | |
| Kala Pharmaceuticals, INC. | $119.19 | 2021 | |
| Rxsight INC | $118.47 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Sun Pharmaceutical Industries INC. | $116.58 | 2019-2023 | Cequa |
| Oyster Point Pharma, INC. | $91.07 | 2023-2025 | Tyrvaya |
| Astellas Pharma US INC | $87.98 | 2024 | Izervay |
| Abbvie INC. | $81.28 | 2022-2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $67.95 | 2019-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $45.18 | 2021 | |
| Coopervision INC. | $31.06 | 2025 | Clariti Contact Lens, Myday Contact Lens |
| The Cameron-Ehlen Group, INC. | $19.72 | 2021 | |
| Sight Sciences, INC. | $16.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.